Accessibility Tools
Here you will find Dynamic42 GmbH news published in the press as well as pictures and flyers for your editorial use. Browse through the download area, subscribe to our newsletter or contact us!
Read here in which articles and contributions Dynamic42 was reported:
Dynamic42 GmbH and EPO Experimental Pharmacology & Oncology are collaborating to advance brain cancer research by integrating organ-on-chip technologies into preclinical drug development.
Read MoreDynamic42 announces the launch of its DynamicOrgan® TEER-Sensor System enabling real-time, non-invasive monitoring of barrier integrity within an organ-on-chip model.
Read MoreDynamic42 GmbH hat den international erfahrenen Manager Wolfgang Kintzel als strategischen Berater gewonnen.
Read MoreDynamic42 announces the launch of its DynamicOrgan® O₂ Sensor Kit enabling continuous, non-invasive monitoring of oxygen levels for human-relevant disease and drug models.
Read MoreDynamic42 GmbH announces the market launch of its Tumor Microenvironment (TME) Kit. The new product enables the creation of perfused 3D tumor models that reproduce the complexity of the human tumor microenvironment.
Read MoreOhio Lumex, a recognized leader in analytical solutions, is proud to announce a new partnership with German biotechnology company Dynamic42. Effective immediately, Ohio Lumex will serve as the exclusive distributor of Dynamic42’s innovative organ-on-chip technology in the United States.
Read More